Funding for this research was provided by:
Foundation for the National Institutes of Health (1R01AG067631-01)
Received: 17 March 2022
Accepted: 6 June 2022
First Online: 19 July 2022
: The DDM trial received Indiana University’s Institutional Review Board approval (1906664366). For participants deemed eligible for enrollment, the patient and/or their legal representative are approached for consent, including for any ancillary studies or specimen collection. Changes to the protocol will be communicated to the Institutional Review Board and to the NIH (if required).
: Consent forms for the trial include consent for publication of results in peer-reviewed journals.
: The authors declare that they have no competing interests.